Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study

Clinical trial NCT02249026 · UNKNOWN

Trial details

NCT number: NCT02249026
Sponsor: Gauda, Estelle B., M.D.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Drug; Withdrawal Symptoms, Neonatal Withdrawal Fetus and Newborn Affected by Other Maternal Medication

Start date: 2014-10-01
Primary completion: 2016-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.